can semaglutide cause diabetic retinopathy GLP-1 receptor agonists and the retina A new study published in

World J Nucl Med

Both semaglutide and tirzepatide are well-known for their effects on weight loss and blood sugar control, but our study suggests they may also offer substantial benefits to patients with obesity and Type 2 diabetes by reducing adverse heart failure outcomes. By analyzing real-world data from over 90,000 HFpEF patients with obesity and Type 2 diabetes, researchers from MGB demonstrated that GLP-1 medications may significantly reduce the risk of hospitalization due to heart failure and all-cause mortality

HCMV induces dysregulation of glutamate uptake and transporter expression in human fetal astrocytes

A few can turn cancerous